Src inhibition is still a relevant target in pancreatic cancer

Oncologist

Volumn 19, Issue 2, 2014, Pages 211-

  George Jr , Thomas J ^a   Trevino, Jose G ^a   Liu, Chen ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DASATINIB; FLUOROURACIL; OXALIPLATIN; PROTEIN TYROSINE KINASE; THYMIDYLATE SYNTHASE; PYRIMIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

CANCER INHIBITION; DRUG TARGETING; ENZYME INHIBITION; HUMAN; LETTER; METASTASIS INHIBITION; PANCREAS CANCER; PRIORITY JOURNAL; SUICIDE GENE THERAPY; ADENOCARCINOMA; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS;

ADENOCARCINOMA; HUMANS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PYRIMIDINES; THIAZOLES;

EID: 84894059672     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0410     Document Type: Letter

References (12)

1. Chee CE, Krishnamurthi S, Nock CJ et al. Phase II study of dasatinib (BMS-354825) in patients with metastatic adenocarcinoma of the pancreas. The Oncologist 2013;18:1091-1092.
2. Kaiser J. Biomedicine. Rare cancer successes spawn "exceptional" research efforts. Science 2013;340:263.
3. Ito H, Gardner-Thorpe J, ZinnerMJ et al. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 2003;134:221-226.
4. Yezhelyev MV, Koehl G, GubaMet al. Inhibition of Src tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice. Clin Cancer Res 2004;10:8028-8036.
5. Nagaraj NS, Smith JJ, Revetta F et al. Targeted inhibition of Src kinase signaling attenuates pancreatic tumorigenesis. Mol Cancer Ther 2010;9: 2322-2332.
6. Trevino JG, Summy JM, Lesslie DP et al. Inhibition of Src expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 2006;168:962-972.
7. DuxburyMS, Ito H, ZinnerMJ et al. Inhibition of Src tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells. Clin Cancer Res 2004;10:2307-2318.
8. Ischenko I, Camaj P, SeeligerHet al. Inhibition of Src tyrosine kinase reverts chemoresistance toward 5-fluorouracil in human pancreatic carcinoma cells: An involvement of epidermal growth factor receptor signaling. Oncogene 2008;27:7212-7222.
9. Treviño JG, Pillai S, Kunigal S et al. Nicotine induces inhibitor of differentiation-1 in a Srcdependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma. Neoplasia 2012;14:1102-1114.
10. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
11. Griffiths GJ, Koh MY, Brunton VG et al. Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin-and Fasinduced apoptosis. J Biol Chem 2004;279:46113-46121.
12. Kopetz S, Lesslie DP, Dallas NA et al. Synergistic activity of the SRC family kinase inhibitor dasatinib andoxaliplatin incolon carcinoma cells is mediated by oxidative stress. Cancer Res 2009;69: 3842-3849.